A Sunstone team update

A Sunstone team update After 17 years as General Partner and co-founder of Sunstone Life Science Ventures and almost 40 years in the life science industry, our colleague Sten Verland will be taking on a part-time role as Venture Partner as of February 1. Sten will...

Sunstone Life Science Ventures divests its holding in Arcoma AB

Sunstone Life Science Ventures divests its holding in Arcoma AB Sunstone announces that one hundred percent of the holding in Arcoma AB have been sold in a structured block sale. Sunstone has been a major owner in Arcoma since 2010 and is proud of what the company has...

IO Biotech, Inc. Announces USD 75 Million Private Placement Financing

IO Biotech, Inc. Announces USD 75 Million Private Placement Financing IO Biotech, Inc. (Nasdaq: IOBT), a clinical biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced that it has entered...